Linking the value of ADC technology to its pioneer
ImmunoGen, a leader in antibody drug conjugate (ADC) technology.
Reinforce ImmunoGen’s reputation as a pioneer in ADC technology by featuring the intricate interrelationship they created between the 3 components of their ADCs.
A distinctive, informative mechanism of action visualization that highlighted ImmunoGen’s expertise while illustrating their unique technology. It was so well received at ASCO that it has since been applied across multiple communication channels to various key stakeholder groups, including clinical investigators, the investment community, and industry partners.
MOA visualization, look and feel, exhibit booth panels, annual report, corporate pipeline brochure, scientific posters, clinical trial logos, invitations, e-mails and collateral material.